AAAAAA
Results: 1-25/33
Authors:
EARLE CC
COYLE D
EVANS WK
Citation: Cc. Earle et al., COST-EFFECTIVENESS ANALYSIS IN ONCOLOGY, Annals of oncology, 9(5), 1998, pp. 475-482
Authors:
EVANS WK
Citation: Wk. Evans, COST-EFFECTIVENESS OF VINORELBINE ALONE OR VINORELBINE PLUS CISPLATINFOR STAGE-IV NSCLC, Oncology, 12(3), 1998, pp. 18-26
Authors:
BROWMAN GP
NEWMAN TE
MOHIDE EA
GRAHAM ID
LEVINE MN
PRITCHARD KI
EVANS WK
MAROUN JA
HODSON DI
CAREY MS
COWAN DH
Citation: Gp. Browman et al., PROGRESS OF CLINICAL ONCOLOGY GUIDELINES DEVELOPMENT USING THE PRACTICE GUIDELINES DEVELOPMENT CYCLE - THE ROLE OF PRACTITIONER FEEDBACK, Journal of clinical oncology, 16(3), 1998, pp. 1226-1231
Authors:
EVANS WK
Citation: Wk. Evans, COMBINED-MODALITY THERAPY FOR LUNG-CANCER - REPLY, Journal of clinical oncology, 16(2), 1998, pp. 808-808
Authors:
EARLE C
COYLE D
SMITH A
AGBOOLA O
EVANS WK
Citation: C. Earle et al., THE COST OF RADIOTHERAPY AT AN ONTARIO REGIONAL CANCER CENTER, European journal of cancer, 33, 1997, pp. 9-9
Authors:
COYLE D
GRUNFELD E
LEVINE M
EVANS WK
Citation: D. Coyle et al., METHODS FOR CONDUCTING ECONOMIC-ANALYSIS OF THE LONG-TERM MANAGEMENT OF BREAST-CANCER - DESCRIPTION OF 2 CURRENT CANADIAN STUDIES, European journal of cancer, 33, 1997, pp. 15-15
Authors:
EVANS WK
LEPETIT C
WILL BP
BERTHELOT JM
TOMIAK E
VERMA S
Citation: Wk. Evans et al., OPPORTUNITIES TO REDUCE THE COST OF CARE FOR BREAST-CANCER (BC) IN CANADA, European journal of cancer, 33, 1997, pp. 20-20
Authors:
EVANS WK
WILL P
BERTHELOT JM
EARLE CC
Citation: Wk. Evans et al., COST OF COMBINED-MODALITY INTERVENTIONS FOR STAGE-III NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(9), 1997, pp. 3038-3048
Authors:
EVANS WK
NEWMAN T
GRAHAM I
RUSTHOVEN JJ
LOGAN D
SHEPHERD FA
CHAMBERLAIN D
Citation: Wk. Evans et al., LUNG-CANCER PRACTICE GUIDELINES - LESSONS LEARNED AND ISSUES ADDRESSED BY THE ONTARIO-LUNG-CANCER-DISEASE-SITE-GROUP, Journal of clinical oncology, 15(9), 1997, pp. 3049-3059
Authors:
STEWART DJ
EVANS WK
SHEPHERD FA
WILSON KS
PRITCHARD KI
TRUDEAU ME
WILSON JJ
MARTZ K
Citation: Dj. Stewart et al., CYCLOPHOSPHAMIDE AND FLUOROURACIL COMBINED WITH MITOXANTRONE VERSUS DOXORUBICIN FOR BREAST-CANCER - SUPERIORITY OF DOXORUBICIN, Journal of clinical oncology, 15(5), 1997, pp. 1897-1905
Authors:
MATHEWS J
GOEL R
EVANS WK
SHAMJI F
STEWART DJ
Citation: J. Mathews et al., ARTERIAL-OCCLUSION IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE TREATED WITH PLATINUM-BASED REGIMENS FOR LUNG-CANCER, Cancer chemotherapy and pharmacology, 40(1), 1997, pp. 19-22
Authors:
EVANS WK
EARLE CC
STEWART DJ
DAHROUGE S
TOMIAK E
GOSS G
LOGAN D
GOEL R
GERTLER SZ
DULUDE H
Citation: Wk. Evans et al., PHASE-II STUDY OF A ONE-HOUR PACLITAXEL INFUSION IN COMBINATION WITH CARBOPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 18(1), 1997, pp. 83-94
Authors:
SHEPHERD FA
CORMIER Y
BURKES R
EVANS WK
GOSS G
KLIMO P
FELD R
TAYLOR M
Citation: Fa. Shepherd et al., PHASE-II TRIAL OF GEMCITABINE AND WEEKLY CISPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 827-830
Authors:
EVANS WK
Citation: Wk. Evans, COST-EFFECTIVENESS OF GEMCITABINE IN STAGE-IV NONSMALL CELL LUNG-CANCER - AN ESTIMATE USING THE POPULATION HEALTH MODEL LUNG-CANCER MODULE, Seminars in oncology, 24(2), 1997, pp. 56-63
Authors:
EVANS WK
LECHEVALIER T
Citation: Wk. Evans et T. Lechevalier, THE COST-EFFECTIVENESS OF NAVELBINE ALONE OR IN COMBINATION WITH CISPLATIN IN COMPARISON TO OTHER CHEMOTHERAPY REGIMENS AND BEST SUPPORTIVECARE IN STAGE-IV NONSMALL CELL LUNG-CANCER, European journal of cancer, 32A(13), 1996, pp. 2249-2255
Authors:
STEWART DJ
TOMIAK EM
GOSS G
GERTLER SZ
LOGAN D
HUAN SS
YAU J
DULUDE H
EVANS WK
Citation: Dj. Stewart et al., PACLITAXEL PLUS HYDROXYUREA AS 2ND LINE THERAPY FOR NONSMALL CELL LUNG-CANCER, Lung cancer, 15(1), 1996, pp. 115-123
Authors:
EVANS WK
WILL BP
BERTHELOT JM
WOLFSON MC
Citation: Wk. Evans et al., THE ECONOMICS OF LUNG-CANCER MANAGEMENT IN CANADA, Lung cancer, 14(1), 1996, pp. 19-29
Authors:
EVANS WK
Citation: Wk. Evans, AN ESTIMATE OF THE COST-EFFECTIVENESS OF GEMCITABINE IN STAGE-IV NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(5), 1996, pp. 82-89
Authors:
EVANS WK
Citation: Wk. Evans, THE HEALTH ECONOMICS OF LUNG-CANCER AND AN ESTIMATE OF THE COST-EFFECTIVENESS OF SINGLE-AGENT GEMCITABINE IN STAGE-IV NSCLC, European journal of cancer, 31A, 1995, pp. 1057-1057
Authors:
LOCHRIN C
GOSS G
CROSS P
STEWART D
TOMIAK E
AGBOOLA O
AREF I
REID K
GIRARD A
LOGAN D
CREPEAU A
DAHROUGE S
EVANS WK
Citation: C. Lochrin et al., CONCURRENT DAILY CHEMOTHERAPY WITH HYPERFRACTIONATED THORACIC IRRADIATION IN STAGE IIIA-AND-B NSCLC, European journal of cancer, 31A, 1995, pp. 1100-1100
Authors:
STEWART DJ
DAHROUGE S
SOLTYS KM
EVANS WK
Citation: Dj. Stewart et al., A PHASE-II STUDY OF 5-FLUOROURACIL PLUS HIGH-DOSE FOLINIC ACID IN THETREATMENT OF RECURRENT SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 18(2), 1995, pp. 130-132
Authors:
EVANS WK
RADWI A
TOMIAK E
LOGAN DM
MARTINS H
STEWART DJ
GOSS G
MAROUN JA
DAHROUGE S
Citation: Wk. Evans et al., ORAL ETOPOSIDE AND CARBOPLATIN - EFFECTIVE THERAPY FOR ELDERLY PATIENTS WITH SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 18(2), 1995, pp. 149-155
Authors:
EVANS WK
Citation: Wk. Evans, ADJUVANT CHEMOTHERAPY - RESULTS AND PERSPECTIVES, Lung cancer, 12, 1995, pp. 35-45
Authors:
EVANS WK
WILL BP
BERTHELOT JM
WOLFSON MC
Citation: Wk. Evans et al., DIAGNOSTIC AND THERAPEUTIC APPROACHES TO LUNG-CANCER IN CANADA AND THEIR COSTS, British Journal of Cancer, 72(5), 1995, pp. 1270-1277
Authors:
HOLMES CE
RUCKDESCHEL JC
JOHNSTON M
THOMAS PA
DESLAURIERS J
GROVER FL
HILL LD
FELD R
GINSBERG RJ
MOUNTAIN CF
DZUIBAN S
KIELY M
MCKNEALLY MF
MOORES DWO
RAMNES C
WAGNER H
BUNN P
CHU H
DIENHART D
HAZUKA M
KINZIE J
SORENSEN J
VANCE V
BRAUN T
HOPEMAN A
KANE M
RUSS P
WHITMAN GJR
FALL SM
HANSEN DP
HENDERSON RH
MONCRIEF CL
PAULING F
SIMS J
TELL D
WISELYCARR S
ABERNATHY CM
CLARK DA
MCCROSKEY B
MOORE G
MOORE F
MYERS A
WHITE M
BROOKS RJ
BULL M
JOHNSON FB
NEIMYR M
PAQUETTE FR
SACCOMANNO G
LAD T
HERMANSEN K
LIEBNER E
MCGUIRE WP
FRY W
STEMPELFELD B
ALEXANDER JC
BECK J
GARCES RM
IMPERATO JP
KAHANDEKAR J
KNOP R
LOCKER G
MERKEL DE
PANELLA JS
ROCHESTER D
VICTOR TA
JOHNSON C
JOOB AW
ROBINSON P
ROSEN S
SHIELDS T
DOOLEY S
TIO FO
HOLLAND C
TREASURE RL
GOTTFRIED B
BEDDINGFIELD G
BOWER J
CHENG D
DALY MB
LADD WA
LEACH C
MURPHY K
QUINTON R
SMITH VC
YOUNG ME
BLANTON M
BRIGGS R
GRISHKIN BA
HELSEL R
JACKSON D
JACKSON ME
YOUNG R
ZALOZNIK A
BLOCK K
DAIL DH
DREIS D
GUYTON SW
HAFERMANN M
HAMMAR SP
JOLLY PC
MORGAN E
SPRINGMEYER S
TAYLOR EW
WEIDEN PW
KNUDSEN N
LIVINGSTON RB
RUSCH VW
GRAFTON C
LERICHE J
MURRAY N
PAGE R
GOODMAN GE
AYE RW
EVANS KG
MILLER RR
NELEMS B
HIGANO C
BERGSAGEL D
BROWN TC
CURTIS J
PAYNE D
PRINGLE JF
QUIRT I
STEWARD L
WARR D
YEOH L
BURKES R
COOTER N
GOLDBERG M
MULLEN B
SCHMOCKER B
HARRIS F
ILVES R
SINCLAIR JM
SPRATT E
BAKER M
CHAMBERLAIN DW
COOPER JD
DESANTIS D
EVANS WK
PATTERSON GA
PEARSON FG
RITCHIE AC
SHEPHERD FA
TAYLOR D
TODD TRJ
WEBSTER J
WINTON TL
KIRBY TJ
LIPA M
FRENCH S
SUTTON D
WARNER E
WATERS PF
JONES D
HOLMES EC
SELCH RA
SHIPLACOFF J
GANZ P
SILVERMAN B
HASKELL C
SADEGHI A
WILLIAMS A
WOLLMAN J
BLOCH JH
CORDER MP
HERMES K
LUKEMAN JM
MURPHY A
PIANTADOSI S
GOODMAN S
RUBINSTEIN LV
GAIL MH
BOSSENGA M
LAKE WH
LONG S
Citation: Ce. Holmes et al., RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER, The Annals of thoracic surgery, 60(3), 1995, pp. 615-622